Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A00012 | Pages: 244 | Charts: 56 | Tables: 113 |
The global digital pathology market size was valued at $735.75 million in 2020, and is expected to reach $1791.30 million by 2030, registering a CAGR of 9.3% from 2021 to 2030. Digital pathology is a computer-enabled, image-based information platform that helps for the management of information generated from digital slides. Growth of the global digital pathology market is majorly driven by increase in prevalence of cancer; rise in the demand for accurate diagnostics, and development of new digital pathology system by large number of key players. According to report published by Medscape, chronic diseases can be associated to the higher mortality rate. The fundamental cause for the development of advanced diagnostic solutions is the rise prevalence of cardiovascular disorders.. Thus, as the prevalence of chronic and cardiovascular diseases rises, the need for digital pathology systems increases driving the growth of the digital pathology market.
Digital pathology technology can aid a research pipeline in two ways. The first one is that the specified file storage and viewing applications may be used to arrange macroscopic images, tissue microarrays, and entire slide images. The second application of digital pathology in research is the development and implementation of image analysis techniques.
Rise in geriatric population and rapid technological advancements in digital pathology systems are the factors that fuel the growth of the digital pathology market. According to the National Cancer Statistics in 2020, around 1,806,590 new cases of cancer in the U.S. Therefore, the growing number of cancer cases can be attributed to the rapid increase in geriatric population which is more prone to cardiac disorders. This is anticipated to boost the growth of the market. In addition, in February 2019, Neuberg Diagnostics and OptraSCAN Inc., announced the launch of Global TELEPath Network for the pathologist community in UAE, India and South Africa under new joint venture namely Neuberg DIGIPATH. Therefore, development of new technologies in digital pathology system has led to increase the growth of the market.
The COVID-19 outbreak is anticipated to have a positive impact to fuel the growth of the global digital pathology market. The Center for Devices and Radiological Health of the U.S. FDA released an enforcement policy for remote digital pathology devices, which are intended for pathologists, clinical laboratories, and drug administration staff. Thus, rise in cases of chronic diseases has increased the usage of digital pathology systems for diagnosis, which is anticipated to drive the digital pathology market during the forecast period.
Thus, new innovations by key players and rise in number of product approvals propel the growth of the market. However, high cost associated with digital pathology systems is expected to hinder the market growth during the forecast period.
The digital pathology market is segmented into type, application, end user, and region. On the basis of type, the market is categorized into scanners, software, and storage & communication systems. On the basis of application, it is divided into teleconsultation, disease diagnosis, drug discovery, and training & education. On the basis of end user, it is categorized into educational, clinical, and pharma & biotech companies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
On the basis of type, the scanners segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for diagnosis of diseases, and surge in adoption of digital pathology systems. However, the disease software segment is expected to witness considerable growth during the forecast period, owing to increase in number of cancer cases and growth in number of key players for development of digital pathology systems in the medical device industry.
[TYPEGRAPH]
On the basis of application, the disease diagnosis segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in number of chronic diseases, rise in the number of cardiac disorders, and increase in demand for digital pathology systems for disease diagnosis. However, the drug discovery is expected to witness considerable growth during the forecast period due to increase in number of cancer cases, rise in use of digital pathology systems, and development of new digital pathology systems in the clinical laboratories.
On the basis of end user, the pharma & biotech companies segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to large number key players offering digital pathology systems, increase in demand for educational practices, development of novel & innovative pathology systems, and advancement in R&D activities. However, the clinical segment is expected to witness considerable growth during the forecast period, owing to increase in cardiovascular diseases, and surge in usage of digital pathology system to determine the efficacy of treatment.
[APPLICATIONGRAPH]
North America dominated the digital pathology market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in number of various types of cancer cases, presence of key players, development of the healthcare sector, and presence of new innovative digital pathology systems in the region. However, Asia-Pacific is expected to register the highest CAGR of 10.6 % from 2021 to 2030, owing to increase in prevalence of chronic diseases, and development of healthcare infrastructure.
[REGIONGRAPH]
The key players that operate in the global digital pathology market include 3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMTSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche, and VisoPharma A/S.
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Use of digital pathology in disease diagnosis
3.4.1.2.Increase in trend of digitalization in the medical sector
3.4.1.3.Ease of consultation
3.4.1.4.Diagnosis in remote regions
3.4.2.Restraints
3.4.2.1.Lack of reimbursement policies
3.4.2.2.High cost of digital pathology solutions
3.4.3.Opportunity
3.4.3.1.Increase in potential of digital pathology
3.4.4.Impact analyses
CHAPTER 4:DIGITAL PATHOLOGY MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Scanners
4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Software
4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Storage and Communication Systems
4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:DIGITAL PATHOLOGY MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Teleconsultation
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Disease diagnosis
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Drug Discovery
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Training & Education
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
CHAPTER 6:DIGITAL PATHOLOGY MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Educational
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Clinical
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Pharma & biotech companies
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
CHAPTER 7:DIGITAL PATHOLOGY MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America market size & forecast, by country
7.2.3.North America market size & forecast, by product
7.2.4.North America market size & forecast, by application
7.2.5.North America market size & forecast, by end user
7.2.6.U.S.
7.2.6.1.U.S. market size & forecast, by product
7.2.6.2.U.S. market size & forecast, by application
7.2.6.3.U.S. market size & forecast, by end user
7.2.7.Canada
7.2.7.1.Canada market size & forecast, by product
7.2.7.2.Canada market size & forecast, by application
7.2.7.3.Canada market size & forecast, by end user
7.2.8.Mexico
7.2.8.1.Mexico market size & forecast, by product
7.2.8.2.Mexico market size & forecast, by application
7.2.8.3.Mexico market size & forecast, by end user
7.3.Europe
7.3.1.Key trends and opportunities
7.3.2.Europe market size & forecast, by country
7.3.3.Europe market size & forecast, by product
7.3.4.Europe market size & forecast, by application
7.3.5.Europe market size & forecast, by end user
7.3.6.Germany
7.3.6.1.Germany market size & forecast, by product
7.3.6.2.Germany market size & forecast, by application
7.3.6.3.Germany market size & forecast, by end user
7.3.7.France
7.3.7.1.France market size & forecast, by product
7.3.7.2.France market size & forecast, by application
7.3.7.3.France market size & forecast, by end user
7.3.8.UK
7.3.8.1.UK market size & forecast, by product
7.3.8.2.UK market size & forecast, by application
7.3.8.3.UK market size & forecast, by end user
7.3.9.Italy
7.3.9.1.Italy market size & forecast, by product
7.3.9.2.Italy market size & forecast, by application
7.3.9.3.Italy market size & forecast, by end user
7.3.10.Spain
7.3.10.1.Spain market size & forecast, by product
7.3.10.2.Spain market size & forecast, by application
7.3.10.3.Spain market size & forecast, by end user
7.3.11.Rest of Europe
7.3.11.1.Rest of Europe market size & forecast, by product
7.3.11.2.Rest of Europe market size & forecast, by application
7.3.11.3.Rest of Europe market size & forecast, by end user
7.4.Asia-Pacific
7.4.1.Key trends and opportunities
7.4.2.Asia-Pacific market size & forecast, by country
7.4.3.Asia-Pacific market size & forecast, by product
7.4.4.Asia-Pacific market size & forecast, by application
7.4.5.Asia-Pacific market size & forecast, by end user
7.4.6.Japan
7.4.6.1.Japan market size & forecast, by product
7.4.6.2.Japan market size & forecast, by application
7.4.6.3.Japan market size & forecast, by end user
7.4.7.China
7.4.7.1.China market size & forecast, by product
7.4.7.2.China market size & forecast, by application
7.4.7.3.China market size & forecast, by end user
7.4.8.Australia
7.4.8.1.Australia market size & forecast, by product
7.4.8.2.Australia market size & forecast, by application
7.4.8.3.Australia market size & forecast, by end user
7.4.9.India
7.4.9.1.India market size & forecast, by product
7.4.9.2.India market size & forecast, by application
7.4.9.3.India market size & forecast, by end user
7.4.10.South Korea
7.4.10.1.South Korea market size & forecast, by product
7.4.10.2.South Korea market size & forecast, by application
7.4.10.3.South Korea market size & forecast, by end user
7.4.11.Rest of Asia-Pacific
7.4.11.1.Rest of Asia-Pacific market size & forecast, by product
7.4.11.2.Rest of Asia-Pacific market size & forecast, by application
7.4.11.3.Rest of Asia-Pacific market size & forecast, by end user
7.5.LAMEA
7.5.1.Key trends and opportunities
7.5.2.LAMEA market size & forecast, by country
7.5.3.LAMEA market size & forecast, by product
7.5.4.LAMEA market size & forecast, by application
7.5.5.LAMEA market size & forecast, by end user
7.5.6.Brazil
7.5.6.1.Brazil market size & forecast, by product
7.5.6.2.Brazil market size & forecast, by application
7.5.6.3.Brazil market size & forecast, by end user
7.5.7.Saudi Arabia
7.5.7.1.Saudi Arabia market size & forecast, by product
7.5.7.2.Saudi Arabia market size & forecast, by application
7.5.7.3.Saudi Arabia market size & forecast, by end user
7.5.8.South Africa
7.5.8.1.South Africa market size & forecast, by product
7.5.8.2.South Africa market size & forecast, by application
7.5.8.3.South Africa market size & forecast, by end user
7.5.9.Rest of LAMEA
7.5.9.1.Rest of LAMEA market size & forecast, by product
7.5.9.2.Rest of LAMEA market size & forecast, by application
7.5.9.3.Rest of LAMEA market size & forecast, by end user
CHAPTER 8:COMPETITIVE LANDSCAPE
8.1.Top player positioning
8.2.Competitive dashboard
8.3.Competitive heatmap
CHAPTER 9:COMPANY PROFILES
9.1.3DHISTECH LTD.
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Key strategic moves and developments
9.2.DANAHER CORPORATION (LEICA MICROSYSTEM)
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.GLENCOE SOFTWARE, INC.
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.4.HAMAMATSU PHOTONICS K.K.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.INDICA LABS INC.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Key strategic moves and developments
9.6.KONINKLIJKE PHILIPS N.V.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.NIKON CORPORATION
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.PERKINELMER INC.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.9.F- HOFFMANN LA-ROCHE (ROCHE)
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.VISIOPHARM A/S
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Key strategic moves and developments
TABLE 01.GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02.DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY REGION, 2018–2026 ($MILLION)
TABLE 03.DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY REGION, 2018–2026 ($MILLION)
TABLE 04.DIGITAL PATHOLOGY MARKET FOR STORAGE AND COMMUNICATION SYSTEMS, BY REGION, 2018–2026 ($MILLION)
TABLE 05.GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 06.DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY REGION, 2018–2026 ($MILLION)
TABLE 07.DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2018–2026 ($MILLION)
TABLE 08.DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY REGION, 2018–2026 ($MILLION)
TABLE 09.DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY REGION, 2018–2026 ($MILLION)
TABLE 10.GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 ($MILLION)
TABLE 11.GLOBAL DIGITAL PATHOLOGY MARKET FOR EDUCATIONAL SECTOR, BY REGION, 2019-2026 ($MILLION)
TABLE 12.DIGITAL PATHOLOGY MARKET FOR CLINICAL SECTOR, BY REGION, 2019-2026 ($MILLION)
TABLE 13.DIGITAL PATHOLOGY MARKET FOR PHARMA & BIOTECH COMPANIES, BY REGION, 2019-2026 ($MILLION)
TABLE 14.DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 15.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 17.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 18.NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 19.U.S. DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 20.U.S. DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 21.U.S. DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 22.CANADA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 23.CANADA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 24.CANADA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 25.MEXICO DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 26.MEXICO DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 27.MEXICO DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 28.EUROPE DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 29.EUROPE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 30.EUROPE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 31.EUROPE DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 32.GERMANY DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 33.GERMANY DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 34.GERMANY DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 35.FRANCE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 36.FRANCE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 37.FRANCE DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 38.UK DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 39.UK DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 40.UK DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 41.ITALY DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 42.ITALY DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 43.ITALY DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 44.SPAIN DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 45.SPAIN DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 46.SPAIN DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 47.REST OF EUROPE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 48.REST OF EUROPE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 49.REST OF EUROPE DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 50.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 51.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 52.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 53.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 54.JAPAN DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 55.JAPAN DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 56.JAPAN DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 57.CHINA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 58.CHINA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 59.CHINA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 60.AUSTRALIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 61.AUSTRALIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 62.AUSTRALIA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 63.INDIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 64.INDIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 65.INDIA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 66.SOUTH KOREA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 67.SOUTH KOREA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 68.SOUTH KOREA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 72.LAMEA DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 73.LAMEA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 74.LAMEA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 75.LAMEA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 76.BRAZIL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 77.BRAZIL DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 78.BRAZIL DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 79.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 80.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 81.SAUDI ARABIA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 82.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 83.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 84.SOUTH AFRICA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 85.REST OF LAMEA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 86.REST OF LAMEA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 87.REST OF LAMEA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
TABLE 88.3DHISTECH: COMPANY SNAPSHOT
TABLE 89.3DHISTECH: PRODUCT PORTFOLIO
TABLE 90.DANAHER: COMPANY SNAPSHOT
TABLE 91.DANAHER: OPERATING SEGMENTS
TABLE 92.DANAHER: PRODUCT PORTFOLIO
TABLE 93.GLENCOE SOFTWARE: COMPANY SNAPSHOT
TABLE 94.GLENCOE SOFTWARE: PRODUCT PORTFOLIO
TABLE 95.HAMAMATSU: COMPANY SNAPSHOT
TABLE 96.HAMAMATSU: OPERATING SEGMENTS
TABLE 97.HAMAMATSU: PRODUCT PORTFOLIO
TABLE 98.INDICA LABS: COMPANY SNAPSHOT
TABLE 99.INDICA LABS: PRODUCT PORTFOLIO
TABLE 100.PHILIPS: COMPANY SNAPSHOT
TABLE 101.PHILIPS: OPERATING SEGMENTS
TABLE 102.PHILIPS: PRODUCT PORTFOLIO
TABLE 103.NIKON: COMPANY SNAPSHOT
TABLE 104.NIKON: OPERATING SEGMENTS
TABLE 105.NIKON: PRODUCT PORTFOLIO
TABLE 106.PERKINELMER: COMPANY SNAPSHOT
TABLE 107.PERKINELMER: OPERATING SEGMENTS
TABLE 108.PERKINELMER: PRODUCT PORTFOLIO
TABLE 109.ROCHE: COMPANY SNAPSHOT
TABLE 110.ROCHE: OPERATING SEGMENTS
TABLE 111.ROCHE: PRODUCT PORTFOLIO
TABLE 112.VISIOPHARM: COMPANY SNAPSHOT
TABLE 113.VISIOPHARM: PRODUCT PORTFOLIO
FIGURE 01.GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS, 2018
FIGURE 03.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.HIGH THREAT OF SUBSTITUTES
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.IMPACT ANALYSES
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR SCANNER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR STORAGE AND COMMUNICATION SYSTEMS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR EDUCATIONAL SECTOR, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR CLINICAL SECTOR, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19.U.S. DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 20.CANADA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 21.MEXICO DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 22.GERMANY DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 23.FRANCE DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 24.UK DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 25.ITALY DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 26.SPAIN DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 27.REST OF EUROPE DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 28.JAPAN DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 29.CHINA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 30.AUSTRALIA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 31.INDIA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 32.SOUTH KOREA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 33.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 34.BRAZIL DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 35.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 36.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 37.REST OF LAMEA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
FIGURE 38.TOP PLAYER POSITIONING, 2018
FIGURE 39.COMPETITIVE DASHBOARD
FIGURE 40.COMPETITIVE HEATMAP OF KEY PLAYERS
FIGURE 41.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.DANAHER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 44.HAMAMATSU: NET SALES, 2018–2020 ($MILLION)
FIGURE 45.PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47.PHILIPS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 48.NIKON: NET SALES, 2018–2020 ($MILLION)
FIGURE 49.NIKON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 50.NIKON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 51.PERKINELMER: NET SALES, 2018–2020 ($MILLION)
FIGURE 52.PERKINELMER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 53.PERKINELMER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 55.ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56.ROCHE: REVENUE SHARE BY REGION, 2020 (%)